Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
One of the best meteor showers of the year peaks at the worst possible time this week - 2Select Your Cherished Fish
- 3Palestinian infant freezes to death in Gaza as Israel keeps blocking aid
- 4Which Store is Your Decision ?
- 5It's your last chance to subscribe to Paramount+ before they raise their prices: Here's how to lock in current pricing
- Top 20 Compelling Business Books for Progress
- Grasping the Commencement of Criminal Cases: An Extensive Outline
- AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
- Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- Steinmeier honours Italian 'guest workers' who rebuilt German economy
- Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18
- The 10 Most Significant Games in History
- What is colostrum? And should you be taking it?
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
